Bo Xie

Title: Bo Xie: Innovator in Pharmaceutical Composition

Introduction

Bo Xie is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. His work focuses on enhancing the efficacy and quality of pharmaceutical products.

Latest Patents

Bo Xie holds a patent for a composition comprising aflibercept and a variant thereof. This patent describes a composition that includes a truncation variant with a truncated VEGF binding portion of aflibercept. The content of the truncation variant is specified to be less than or equal to about 20% by mass percentage. Additionally, the patent outlines a pharmaceutical formulation that incorporates this composition. It also provides methods for detecting the variant and its use in quality inspection or quality control of aflibercept-containing products. This innovation is crucial for ensuring the quality and effectiveness of pharmaceutical formulations.

Career Highlights

Bo Xie is associated with Qilu Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His role at the company allows him to apply his expertise in developing advanced pharmaceutical solutions. His contributions have been instrumental in the company's research and development efforts.

Collaborations

Bo Xie has collaborated with notable colleagues, including Yue Yu and Guijiang Wang. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Bo Xie's work exemplifies the impact of innovation in the pharmaceutical industry. His patent on aflibercept compositions highlights his commitment to improving drug formulations and quality control processes. His contributions continue to influence the development of effective pharmaceutical products.